Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Silicone breast implant access by reconstruction patients to be improved -- FDA petition response.

This article was originally published in The Gray Sheet

Executive Summary

SILICONE BREAST IMPLANT ACCESS TO BE IMPROVED FOR RECONSTRUCTION PATIENTS, FDA says in an Oct. 15 response to a citizen's petition. In the response, signed by FDA Lead Deputy Commissioner Michael Friedman, the agency says that although it still does not have enough data to lift current restrictions on silicone breast implant availability, it will take specific steps to ensure that breast reconstruction patients have access to the products. The petition, submitted in September 1996 by the Y-ME National Breast Cancer Organization, sought broader availability of the implants.
Advertisement
Advertisement
UsernamePublicRestriction

Register

MT009032

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel